Skip to main content

신희철 교수

Hee Chul Shin

서울대학교 · 생화학·유전·분자생물학

연구실 소개

신희철 교수의 연구실은 암의 분자적 기전과 생물학적 마커를 중심으로, 특히 유전적 변형과 생체 정보를 기반으로 한 암 조기 진단 및 개인 맞춤 치료 전략을 개발하고 있습니다. 주로 암의 유전적 특성과 전이성 병소 간의 수용체 상태 변화를 분석하여 치료 반응 예측 및 환자 관리 개선에 기여하고 있으며, 신규 바이오마커 및 NGS 기반 다유전자 패널 검사의 임상적 활용 가능성을 탐색하고 있습니다. 특히 유방암의 전이성 병소에서의 수용체 상태 이질성과 관련된 임상적 영향을 규명하는 데 초점을 맞추고 있습니다.

유전자 패널 검사암 생물학전이성 병소수용체 상태 이질성개인 맞춤 치료

연구 현황

논문 수
242
총 인용 수
1,600
최근 5년 논문
123
주요 분야
생화학·유전·분자생물학

연구 성과 추이

표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.

5개년 연도별 논문 게재 수
123총합
2022
2023
2024
2025
2026
5개년 연도별 피인용 수
174총합
20222023202420252026

주요 논문

15
1
논문|인용수 167·1998
Phenotype and Genotype of Advanced Premalignant Head and Neck Lesions After Chemopreventive Therapy
Li Mao, V. Papadimitrakopoulou, Dong M. Shin, You-Hong Fan, Xiaogen Zhou, J. S. Lee, W. K. Hong, A. K. El-Naggar, Hee‐Chul Shin, Gary L. Clayman, J. Jack Lee, WN Hittelman
SJR Q1FWCI 8.7JNCI Journal of the National Cancer InstituteOA

Our data suggest that clinical and histologic assessments of the response to chemopreventive agents may be insufficient to determine their efficacy and that critical genetic alterations could be used as independent biomarkers to augment the ability to evaluate the efficacy of such agents.

Pathology and Forensic MedicineMedicine
2
논문|인용수 99·1996
Thin gate oxide damage due to plasma processing
Hee‐Chul Shin, Chenming Hu
SJR Q2FWCI 10.4Semiconductor Science and Technology

Plasma processes cause current to flow through the thin oxide and the resultant plasma-induced damage can be simulated and modelled as damage produced by constant-current (or voltage) electrical stress. Plasma processing causes MOSFET parameter degradation, from which one can deduce the plasma charging current. Since the scattering of post-damage device parameters is due to a reproducible variation of stress current across the wafer, one can easily analyse the effect of device geometry on damage

Electrical and Electronic EngineeringEngineering
3
논문|인용수 71·2013
Breast-Conserving Surgery After Tumor Downstaging by Neoadjuvant Chemotherapy is Oncologically Safe for Stage III Breast Cancer Patients
Hee‐Chul Shin, Wonshik Han, Hyeong‐Gon Moon, Seock‐Ah Im, Woo Kyung Moon, In-Ae Park, Sung Jun Park, Dong‐Young Noh
SJR Q1FWCI 2.2Annals of Surgical Oncology
Cancer ResearchBiochemistry, Genetics and Molecular Biology
4
논문|인용수 54·2012
Limited Value and Utility of Breast MRI in Patients Undergoing Breast-Conserving Cancer Surgery
Hee‐Chul Shin, Wonshik Han, Hyeong‐Gon Moon, Cha Kyong Yom, Soo Kyung Ahn, Jee-Man You, Jisun Kim, Jung Min Chang, Nariya Cho, Woo Kyung Moon, In-Ae Park, Dong‐Young Noh
SJR Q1FWCI 5.7Annals of Surgical Oncology
Radiology, Nuclear Medicine and ImagingMedicine
5
논문|인용수 52·2012
Nomogram for predicting positive resection margins after breast-conserving surgery
Hee‐Chul Shin, Wonshik Han, Hyeong‐Gon Moon, Nariya Cho, Woo Kyung Moon, In-Ae Park, Sung Jun Park, Dong‐Young Noh
SJR Q1FWCI 1.9Breast Cancer Research and Treatment
Cancer ResearchBiochemistry, Genetics and Molecular Biology
6
논문|인용수 41·2020
Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test
Hee-Chul Shin, Han‐Byoel Lee, Tae-Kyung Yoo, Eun-Shin Lee, Ryong Nam Kim, Boyoung Park, Kyong‐Ah Yoon, Charny Park, Eun Sook Lee, Hyeong‐Gon Moon, Dong‐Young Noh, Sun‐Young Kong
SJR Q1FWCI 5.0Cancer Research and TreatmentOA

NGS-based multiple-gene panel testing improved the detection rates of deleterious mutations and provided a cost-effective cancer risk assessment.

GeneticsBiochemistry, Genetics and Molecular Biology
7
논문|인용수 13·2023
Recurrence is Not Associated with Margin Status in Phyllodes Tumor
Kyung-Hwak Yoon, Eunyoung Kang, Eun‐Kyu Kim, So Yeon Park, Hee-Chul Shin
SJR Q1FWCI 3.3Annals of Surgical Oncology
Pathology and Forensic MedicineMedicine
8
논문|인용수 11·2016
Relapse of Biphenotypic Acute Leukemia as a Breast Mass
Hee‐Chul Shin
SJR Q2FWCI 0.2Journal of Breast CancerOA

In acute leukemia, leukemic infiltration of the breast is extremely rare. We report a case of biphenotypic acute leukemia (BAL) that presented as a breast mass. A 30-year-old woman presented with a 4-month history of a right breast mass with nipple discharge and easy fatigue. She had received chemotherapy and peripheral blood stem cell transplantation for BAL and had been in complete remission for the last 2 years. Core needle biopsy of the breast mass revealed monomorphous infiltrates of blast

HematologyMedicine
9
논문|인용수 8·2016
Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis
Hee-Chul Shin, Wonshik Han, Hyeong‐Gon Moon, In-Ae Park, Dong‐Young Noh
SJR Q2FWCI 0.4Journal of Breast CancerOA

Discordance in receptor status and tumor phenotype between primary breast cancer and corresponding metastatic lesions was observed. Patients with concordant TNP had worse long-term outcomes than patients with concordant non-TNP and discordant TNP between primary and metastatic breast cancer. Identifying the receptor status of metastatic lesions may lead to improvements in patient management and survival.

Cancer ResearchBiochemistry, Genetics and Molecular Biology
10
논문|인용수 7·2016
Clinical benefit of nomogram for predicting positive resection margins in breast conserving surgery
E.-S. Lee, Wonshik Han, Hee-Chul Shin, Masahiro Takada, Han Suk Ryu, N. Cho, M. K. Kim, Jinna Kim, Taewook Yoo, Hyeong‐Gon Moon, Masakazu Toi, Woo Kyung Moon
SJR Q1FWCI 0.1European Journal of Surgical Oncology
Cancer ResearchBiochemistry, Genetics and Molecular Biology
11
논문|인용수 6·2014
Sarcoidosis Mimicking Metastatic Breast Cancer in Korean Woman with Breast Cancer
Hee‐Chul Shin, Ju Won Choe, Han Suk Ryu, Hee Sung Kim, Jong Wook Shin, Yang Soo Kim, Sung Jun Park
SJR Q2FWCI 0.5The Breast Journal
PhysiologyMedicine
12
논문|인용수 2·2013
Discordant ER, PR, and HER2 status between primary and metastatic breast cancer as prognostic factor.
Hee‐Chul Shin, Wonshik Han, Hyeong‐Gon Moon, Seock‐Ah Im, Woo Kyung Moon, In-Ae Park, Sung Jun Park, Dong‐Young Noh
SJR Q1Journal of Clinical Oncology

1039 Background: The receptor status including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) of metastases may be different from that of the primary breast cancer. This discordance of receptor status may influence patient prognosis. We investigated discordance of receptor status between primary breast cancer and distant metastases in the same patients and its effect on prognosis. Methods: ER, PR, and HER2 status in metastases were availab

OncologyMedicine
13
논문|인용수 1·2017
Frequency of germline patghogenic mutation in breast cancer patients at high risk hereditary cancer.
Hee‐Chul Shin, Wonshik Han, Han‐Byoel Lee, Hyeong‐Gon Moon, Eun-Shin Lee, Dong‐Young Noh
SJR Q1FWCI 0.2Journal of Clinical Oncology

e13110 Background: Next-generation sequencing technology allows the simultaneous sequencing of multiple target genes. We developed a gene panel containing 64 genes which were associated with various hereditary cancers. This study was performed to evaluate the frequency of pathogenic mutations associated with hereditary cancer among Korean patients at high risk hereditary breast cancer using multi-gene sequencing panel. Methods: A total of 252 breast cancer patients with high-risk hereditary canc

GeneticsBiochemistry, Genetics and Molecular Biology
14
논문|인용수 1·2009
Experience with Enterostomy Closure in Very Low Birth Weight Infants
Hee-Chul Shin, Suk-Bae Moon, Seong Cheol Lee, Sung Eun Jung, Kwi Won Park
Journal of the Korean Association of Pediatric SurgeonsOA
SurgeryMedicine
15
논문|인용수 1·2015
Reliability of ER, PR, and HER2 status in core needle biopsy.
Hee‐Chul Shin, Hee Ju Sohn, Hee Sung Kim, Sung Jun Park
SJR Q1Journal of Clinical Oncology

e11503 Background: It has become important in the preoperative work up of breast cancer patients to analyze estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki67 in core needle biopsy (CNB). These factors reflect response or resistance to endocrine therapy, chemotherapy and target therapy. Furthermore, factors help to select adjuvant or neoadjuvant treatment. For accuracy of ER, PR, HER2, and Ki67 in CNB, we compared the results of CNB and

Pathology and Forensic MedicineMedicine

대표 연구 분야

GeneticsOncologyCancer ResearchSurgeryPathology and Forensic MedicineElectrical and Electronic Engineering

신희철 교수의 연구를 Nubint에서 더 깊이 살펴보세요

이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.